Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Sponsor : Yichang Humanwell Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Intravenous Hydromorphone for the Treatment of Acute Pain
Details : Hydromorphone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Chest Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 29, 2025
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Sponsor : Yichang Humanwell Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Personalization of Opioid Prescription Following Orthognathic Surgery
Details : Hydromorphone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain, Postoperative.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 01, 2023
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Exalgo (Hydromorphone HCl) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Chronic Pain.
Product Name : Exalgo
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 22, 2014
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Masimo
Deal Size : Inapplicable
Deal Type : Inapplicable
Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries
Details : Hydromorphone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 31, 2013
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Masimo
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hydromorphone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 04, 2013
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Respiratory Depression When Using a Hydromorphone Pain Protocol
Details : Hydromorphone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 06, 2013
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration
Details : Hydromorphone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Chronic Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 18, 2012
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration
Details : Hydromorphone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Chronic Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 18, 2012
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hydromorphone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 24, 2012
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hydromorphone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cancer Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 18, 2012
Lead Product(s) : Hydromorphone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable